Clinical outcomes and molecular typing of heterogenous vancomycin-intermediate Staphylococcus aureus bacteremia in patients in intensive care units

BACKGROUND: Staphylococcus aureus is one of most common pathogens in humans. Methicillin-resistant S. aureus (MRSA) accounts for 64 % of S. aureus bacteremia isolated in intensive care units (ICUs), and heteroresistant vancomycin-intermediates S. aureus (hVISA) is a phenotype of MRSA. However, studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Han-Chung, Kao, Kuo-Chin, Chiu, Li-Chung, Chang, Chih-Hao, Hung, Chen-Yiu, Li, Li-Fu, Liu, Tsui-Ping, Lin, Lee-Chung, Chen, Ning-Hung, Huang, Chung-Chi, Yang, Cheng-Ta, Lu, Jang-Jih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619030/
https://www.ncbi.nlm.nih.gov/pubmed/26497595
http://dx.doi.org/10.1186/s12879-015-1215-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619030/
https://www.ncbi.nlm.nih.gov/pubmed/26497595
http://dx.doi.org/10.1186/s12879-015-1215-2

Ejemplares similares